Pasi Score Calculator
Calculate Psoriasis Area and Severity Index from body region involvement and lesion severity. Enter values for instant results with step-by-step formulas.
Calculator
Adjust values & calculateHead (10% BSA)
Trunk (30% BSA)
Upper Extremities (20% BSA)
Lower Extremities (40% BSA)
Formula
Where A = area score (0-6), E = erythema (0-4), I = induration (0-4), D = desquamation (0-4) for each region. Weighting: head (h) = 0.1, trunk (t) = 0.3, upper extremities (u) = 0.2, lower extremities (l) = 0.4. Total PASI ranges from 0 (clear) to 72 (maximum severity).
Last reviewed: January 2026
Worked Examples
Example 1: Moderate Plaque Psoriasis Assessment
Example 2: Treatment Response at 12 Weeks
Background & Theory
The Pasi Score Calculator applies the following established principles and formulas. Health and medicine calculators are grounded in validated physiological measurement methods established through decades of clinical research. Body Mass Index, or BMI, is calculated by dividing weight in kilograms by height in meters squared (kg/m²), a formula originating from Adolphe Quetelet's 19th-century statistical work and later codified by the WHO into standard classifications: underweight below 18.5, normal weight 18.5 to 24.9, overweight 25 to 29.9, and obese at 30 and above. Basal Metabolic Rate quantifies the minimum energy required to sustain life at rest. The Mifflin-St Jeor equation, published in 1990 and widely regarded as the most accurate for most adults, calculates BMR as (10 × weight in kg) + (6.25 × height in cm) − (5 × age) ± sex adjustment. The older Harris-Benedict equations, revised in 1984 by Roza and Shizgal, remain in common use. Total Daily Energy Expenditure is derived by multiplying BMR by a physical activity factor ranging from 1.2 for sedentary individuals to 1.9 for extremely active ones, following the methodology validated by doubly labeled water studies. Body fat percentage can be estimated without laboratory equipment using the U.S. Navy circumference method, which uses neck, waist, and hip measurements, or via BMI-derived equations adjusted for age and sex. The Jackson-Pollock skinfold method offers higher precision with calipers. Blood pressure classification, according to the American College of Cardiology and the 2017 ACC/AHA guidelines, defines normal as below 120/80 mmHg, elevated as 120 to 129 systolic, and hypertension stage 1 as 130 to 139 systolic or 80 to 89 diastolic. Target heart rate zones for aerobic exercise are derived from maximum heart rate estimates, most commonly using the formula 220 minus age in years, with moderate-intensity training typically defined as 50 to 70 percent of maximum heart rate and vigorous intensity at 70 to 85 percent, consistent with CDC and American Heart Association guidelines. These thresholds guide safe and effective cardiovascular conditioning.
History
The history behind the Pasi Score Calculator traces back through the following developments. The history of health measurement stretches back to ancient Greece, where Hippocrates around 400 BCE laid the foundation for observational medicine by systematically recording patient symptoms, diet, and environment. His humoral theory, though scientifically superseded, established the principle that the body operates as an interconnected system subject to measurable imbalance. The transformation toward modern medicine accelerated in the 19th century. Louis Pasteur and Robert Koch developed germ theory in the 1860s and 1870s, identifying microorganisms as disease agents and enabling targeted interventions. Florence Nightingale, working during the Crimean War in the 1850s, introduced statistical analysis to nursing practice, demonstrating through data visualization that sanitation reduced mortality. Her work is foundational to evidence-based health measurement. The discovery of vitamins in the early 20th century, beginning with Casimir Funk's coinage of the term in 1912 and culminating in the isolation of vitamins A through K, created the field of nutritional science and gave rise to dietary reference intake frameworks. The World Health Organization, founded in 1948, subsequently established global standards for health metrics, disease classification through the International Classification of Diseases, and recommended daily allowances. The BMI as a clinical screening tool gained traction in the 1970s through Ancel Keys' large-scale epidemiological work, which validated Quetelet's index as a population-level obesity indicator. Through the 1980s and 1990s, the Framingham Heart Study produced landmark data linking cholesterol, blood pressure, and lifestyle factors to cardiovascular disease risk, directly shaping the numeric thresholds still used in health calculators. The evidence-based medicine movement, formalized by Gordon Guyatt and colleagues at McMaster University in the early 1990s, demanded that all health recommendations derive from systematically graded clinical evidence. The digital health era beginning in the 2000s brought these formulas to consumer devices, wearable sensors, and smartphone applications, expanding access to health self-monitoring on a global scale and enabling population-level data collection that continues to refine clinical reference ranges.
Frequently Asked Questions
Formula
PASI = 0.1(Ah)(Eh+Ih+Dh) + 0.3(At)(Et+It+Dt) + 0.2(Au)(Eu+Iu+Du) + 0.4(Al)(El+Il+Dl)
Where A = area score (0-6), E = erythema (0-4), I = induration (0-4), D = desquamation (0-4) for each region. Weighting: head (h) = 0.1, trunk (t) = 0.3, upper extremities (u) = 0.2, lower extremities (l) = 0.4. Total PASI ranges from 0 (clear) to 72 (maximum severity).
Worked Examples
Example 1: Moderate Plaque Psoriasis Assessment
Problem: A patient has: Head - area 2, erythema 2, induration 2, scaling 1. Trunk - area 3, erythema 2, induration 2, scaling 2. Upper limbs - area 2, erythema 2, induration 1, scaling 1. Lower limbs - area 3, erythema 2, induration 2, scaling 2. Calculate PASI.
Solution: Head: 0.1 x 2 x (2+2+1) = 0.1 x 2 x 5 = 1.0\nTrunk: 0.3 x 3 x (2+2+2) = 0.3 x 3 x 6 = 5.4\nUpper: 0.2 x 2 x (2+1+1) = 0.2 x 2 x 4 = 1.6\nLower: 0.4 x 3 x (2+2+2) = 0.4 x 3 x 6 = 7.2\nTotal PASI = 1.0 + 5.4 + 1.6 + 7.2 = 15.2
Result: PASI: 15.2 | Moderate Psoriasis | PASI 75 target: 3.8
Example 2: Treatment Response at 12 Weeks
Problem: Baseline PASI was 22.0. At 12 weeks on biologic therapy, PASI is 4.4. Calculate response level.
Solution: Baseline PASI: 22.0\nCurrent PASI: 4.4\nAbsolute reduction: 22.0 - 4.4 = 17.6\nPercent reduction: (17.6/22.0) x 100 = 80%\nPASI 75 threshold: 22.0 x 0.25 = 5.5 (achieved, current 4.4 < 5.5)\nPASI 90 threshold: 22.0 x 0.10 = 2.2 (not yet achieved)\nResponse: PASI 75 achieved, approaching PASI 90
Result: 80% improvement | PASI 75 achieved | Continue current therapy
Frequently Asked Questions
What is the PASI score and why is it important in dermatology?
The Psoriasis Area and Severity Index (PASI) is the gold standard clinical tool for measuring psoriasis severity, combining assessment of body surface area involvement with lesion characteristics. Developed by Fredriksson and Pettersson in 1978, it evaluates four body regions (head, trunk, upper extremities, and lower extremities) across three lesion parameters: erythema (redness), induration (thickness), and desquamation (scaling). PASI scores range from 0 to 72, with higher scores indicating more severe disease. The PASI is the primary endpoint in virtually all clinical trials of psoriasis treatments and is required by regulatory agencies including the FDA and EMA for drug approval in psoriasis. It provides a standardized, reproducible measure for tracking disease progression and treatment response.
How is the PASI score calculated step by step?
The PASI score is calculated by evaluating four body regions separately and then combining their weighted contributions. For each region (head, trunk, upper extremities, lower extremities), the clinician rates three lesion characteristics on a 0-4 scale: erythema, induration, and desquamation. These three severity scores are summed for each region. The area of involvement for each region is graded on a 0-6 scale (0 = none, 1 = less than 10%, up to 6 = 90-100%). Each region score equals the area grade multiplied by the severity sum. Regional scores are then multiplied by body surface area weighting factors: head = 0.1, trunk = 0.3, upper extremities = 0.2, and lower extremities = 0.4. The final PASI is the sum of all four weighted regional scores.
What do different PASI score ranges indicate about disease severity?
PASI scores are categorized into severity bands that guide clinical management decisions. A PASI of 0 indicates clear or completely resolved psoriasis. Scores from 0.1 to 5 represent mild psoriasis, typically manageable with topical treatments alone. Scores between 5 and 10 indicate mild-to-moderate disease that may require phototherapy or systemic therapy. Scores above 10 are generally classified as moderate-to-severe psoriasis warranting systemic or biologic therapy. Scores above 20 indicate severe psoriasis requiring aggressive intervention. In clinical trials, PASI thresholds of 10 or 12 are commonly used as inclusion criteria for moderate-to-severe disease. Most dermatology guidelines now use PASI alongside body surface area and quality-of-life measures for comprehensive severity classification.
What are PASI 75, PASI 90, and PASI 100 response criteria?
PASI response criteria express the percentage improvement from baseline PASI score and are the standard endpoints in psoriasis clinical trials. PASI 75 means a 75% or greater reduction from baseline PASI and has traditionally been the primary efficacy endpoint in most clinical trials. PASI 90 represents a 90% or greater reduction and is increasingly used as the primary endpoint for newer biologic therapies that achieve higher clearance rates. PASI 100 indicates complete clearance of all psoriasis lesions. For example, a patient with baseline PASI of 20 would need to achieve PASI 5 or lower for PASI 75, PASI 2 or lower for PASI 90, and PASI 0 for PASI 100. Modern biologic therapies like IL-17 and IL-23 inhibitors commonly achieve PASI 90 rates of 60-80%.
How reliable is the PASI score between different clinicians?
Inter-rater reliability of PASI scoring has been a persistent concern in dermatology research. Studies show moderate to good inter-rater agreement with intraclass correlation coefficients ranging from 0.60 to 0.85 depending on training and experience. The area component tends to have lower reliability than the severity components because estimating percentage body surface area involvement is inherently subjective. Training programs and photographic reference atlases can improve consistency. Erythema assessment can be challenging in patients with darker skin types due to reduced contrast between inflamed and uninflamed skin. Despite these limitations, PASI remains the most widely used psoriasis severity measure because alternatives have not demonstrated clearly superior reliability while maintaining the same breadth of clinical validation and regulatory acceptance.
What are the limitations of using PASI as the primary severity measure?
PASI has several well-recognized limitations despite its widespread use. It does not capture important aspects of psoriasis burden such as symptoms (itch, pain, burning), quality of life impact, joint involvement, or nail and scalp disease severity. The scoring system has limited sensitivity at lower disease severity levels, making it less useful for differentiating between mild and very mild psoriasis. PASI cannot distinguish between different clinical subtypes of psoriasis (plaque, guttate, pustular, erythrodermic). The mathematical weighting system may undervalue highly visible areas like the face and hands. Additionally, patients with identical PASI scores may have vastly different disease patterns and functional impact. For these reasons, modern guidelines recommend using PASI alongside patient-reported outcomes like DLQI and body surface area assessment.
References
Reviewed by Rahul Singh, Health & Wellness Specialist · Editorial policy